Kissei Pharmaceutical Co Ltd
TSE:4547

Watchlist Manager
Kissei Pharmaceutical Co Ltd Logo
Kissei Pharmaceutical Co Ltd
TSE:4547
Watchlist
Price: 3 555 JPY 0.99% Market Closed
Market Cap: 152.2B JPY
Have any thoughts about
Kissei Pharmaceutical Co Ltd?
Write Note
Kissei Pharmaceutical Co Ltd
/
Income Statement
/
Operating Income

Kissei Pharmaceutical Co Ltd
Operating Income

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Kissei Pharmaceutical Co Ltd
Operating Income Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Operating Income CAGR 3Y CAGR 5Y CAGR 10Y
Kissei Pharmaceutical Co Ltd
TSE:4547
Operating Income
¥3.8B
CAGR 3-Years
N/A
CAGR 5-Years
-2%
CAGR 10-Years
-11%
Takeda Pharmaceutical Co Ltd
TSE:4502
Operating Income
¥541.9B
CAGR 3-Years
-10%
CAGR 5-Years
18%
CAGR 10-Years
16%
Daiichi Sankyo Co Ltd
TSE:4568
Operating Income
¥303.4B
CAGR 3-Years
50%
CAGR 5-Years
22%
CAGR 10-Years
10%
Otsuka Holdings Co Ltd
TSE:4578
Operating Income
¥400.1B
CAGR 3-Years
30%
CAGR 5-Years
26%
CAGR 10-Years
6%
Chugai Pharmaceutical Co Ltd
TSE:4519
Operating Income
¥540.2B
CAGR 3-Years
15%
CAGR 5-Years
24%
CAGR 10-Years
21%
Astellas Pharma Inc
TSE:4503
Operating Income
¥120.4B
CAGR 3-Years
-10%
CAGR 5-Years
-16%
CAGR 10-Years
-3%
No Stocks Found

Kissei Pharmaceutical Co Ltd
Glance View

Market Cap
157.1B JPY
Industry
Pharmaceuticals

Kissei Pharmaceutical Co., Ltd. engages in the research, development, manufacture and sale of pharmaceutical products and health foods. The company is headquartered in Matsumoto-Shi, Nagano-Ken and currently employs 1,863 full-time employees. is a Japan-based company mainly engaged in the manufacture and sale of pharmaceutical products. The firm is engaged in the collection and analysis of medicine development information, and the manufacture and sale of medicines. The company is also engaged in the purchase and sale of related materials, system development and information process work, construction contract work such as new construction, expansion and renovation of factories, laboratories and offices, the management of facility and equipment work, information collection and development support work, noodle manufacture and sale, and insurance agency business.

Intrinsic Value
2 516.78 JPY
Overvaluation 29%
Intrinsic Value
Price
What is Intrinsic Value?

See Also

What is Kissei Pharmaceutical Co Ltd's Operating Income?
Operating Income
3.8B JPY

Based on the financial report for Sep 30, 2024, Kissei Pharmaceutical Co Ltd's Operating Income amounts to 3.8B JPY.

What is Kissei Pharmaceutical Co Ltd's Operating Income growth rate?
Operating Income CAGR 10Y
-11%

Over the last year, the Operating Income growth was 150%.

Back to Top
ALPHA SPREAD
Follow us
Join more than 210,800+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.